|
期刊名称：JOURNAL OF THORACIC ONCOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Scope
Journal of Thoracic Oncology, the official journal of the International Association for the Study of Lung Cancer, is the primary educational and informational publication for topics relevant to detection, prevention, diagnosis, and treatment of thoracic malignancies. JTO emphasizes a multidisciplinary approach, and includes original research (clinical trials and translational or basic research), reviews, and opinion pieces. The audience consists of epidemiologists, medical oncologists, radiation oncologists, thoracic surgeons, pulmonary specialists, radiologists, pathologists, and research scientists with a special interest in thoracic oncology.
Instructions to Authors
Manuscript Submission
On-line manuscript submission: All manuscripts must be submitted on-line through the Web site at http://jto.edmgr.com.
First-time users: Please click the Register button from the main menu and enter the requested information. On successful registration, you will be sent an e-mail indicating your user name and password. Print a copy of this information for future reference. Note: If you have received an e-mail from us with an assigned user ID and password, or if you are a repeat user, do not register again. Just log in. Once you have an assigned ID and password, you do not have to re-register, even if your status changes (that is, author, reviewer, or editor).
Authors: Please click the log-in button from the menu at the top of the page and log in to the system as an Author. Submit your manuscript according to the author instructions. You will be able to track the progress of your manuscript through the system.
Preparation of Manuscript
Manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review.
Title page: The title page must be submitted as a separate file. Include on the title page (a) complete manuscript title; (b) authors¡¯ full names, highest academic degrees, and affiliations; (c) name and address for correspondence, including fax number, telephone number, and e-mail address; (d) address for reprints if different from that of corresponding author; and (e) all sources of support, including pharmaceutical and industry support, that require acknowledgment. Research supported in whole or part by the tobacco industry will not be considered for publication in JTO.
Structured Abstracts: Limit the abstract to 250 words. Do not cite references in the abstract. Limit the use of abbreviations and acronyms. Use the following subheads: Introduction or Hypothesis, Methods, Results, and Conclusions. List three to five key words. Examples of key words: small cell, mesothelioma, bronchoscopic ultrasound.
Text: Organize the manuscript into four main headings: Introduction, Materials and Methods, Results, and Discussion. Define abbreviations at first mention in text and in each table and figure. If a brand name is cited, supply the manufacturer's name and address (city and state/country).
Abbreviations: For a list of standard abbreviations, consult the Council of Biology Editors Style Guide (available from the Council of Science Editors, 9650 Rockville Pike, Bethesda, MD 20814,www.councilscienceeditors.org) or other standard sources. Write out the full term for each abbreviation at its first use unless it is a standard unit of measure.
References: The authors are responsible for the accuracy of the references. Key the references (double-spaced) at the end of the manuscript. Cite the references in text in the order of appearance. Cite unpublished data¡ªsuch as papers submitted but not yet accepted for publication and personal communications, including e-mail communications¡ªin parentheses in the text. If there are more than three authors, name only the first three authors and then use et al. Refer to the List of Journals Indexed in Index Medicus for abbreviations of journal names, or access the list at http://www.nlm.nih.gov/tsd/serials/lji.html. Sample references are given below:
Journal article
1. Rand NS, Dawson JM, Juliao SF, et al. In vivo macrophage recruitment by murine intervertebral disc cells. J Spinal Disord 2001;14:339--342.
Book chapter
2. Todd VR. Visual information analysis: frame of reference for visual perception. In: Kramer P, Hinojosa J, eds. Frames of Reference for Pediatric Occupational Therapy. Philadelphia, PA: Lippincott Williams & Wilkins; 1999:205¨C256.
Entire book
3. Kellman RM, Marentette LJ. Atlas of Craniomaxillofacial Fixation. Philadelphia, PA: Lippincott Williams & Wilkins; 1999.
Software
4. Epi Info [computer program]. Version 6. Atlanta, GA: Centers for Disease Control and Prevention; 1994.
Online journals
5. Friedman SA. Preeclampsia: a review of the role of prostaglandins. Obstet Gynecol [serial online]. January 1988;71:22-37. Available from: BRS Information Technologies, McLean, VA. Accessed December 15, 1990.
Database
6. CANCERNET-PDQ [database online]. Bethesda, MD: National Cancer Institute; 1996. Updated March 29, 1996.
World Wide Web
7. Gostin LO. Drug use and HIV/AIDS [JAMA HIV/AIDS Web site]. June 1, 1996. Available at: http://www.ama-assn.org/special/hiv/ethics. Accessed June 26, 1997.
Figures: Digital art should be created/scanned and saved and submitted as either a TIFF (tagged image file format), an EPS (encapsulated postscript) file. PPT (Power Point) files will also be accepted. Electronic photographs¡ªradiographs, CT scans, and so on¡ªand scanned images must have a resolution of at least 300 dpi. Line art must have a resolution of at least 1200 dpi (dots per inch). If fonts are used in the artwork, they must be converted to paths or outlines or they must be embedded in the files. Color images must be created/scanned and saved and submitted as CMYK files. If you do not have the capability to create CMYK files, please disregard this step. Indicate in your cover letter that you are unable to produce CMYK files. Cite figures consecutively in the text, and number them in the order in which they are discussed.
Detailed Figure Instructions: For a step by step guide for submitting Digital Art please visit www.LWWonline.com. Click ¡°For Authors¡± and click ¡°Digital Art Checklist¡± and ¡°5 Steps for Creating Digital Artwork¡± in the menu to the right.
Figure legends: Include legends for all figures. They should be brief and specific, and they should appear on a separate manuscript page after the references. Use scale markers in the image for electron micrographs, and indicate the type of stain used.
Color figures: The journal accepts for publication color figures that will enhance an article at no charge to the author.
Tables: Create tables using the table creating and editing feature of your word processing software (eg, Word, WordPerfect). Do not use Excel or comparable spreadsheet programs. Group all tables in a separate file. Cite tables consecutively in the text, and number them in that order. Each table should appear on a separate sheet and should include the table title, appropriate column heads, and explanatory legends (including definitions of any abbreviations used). Do not embed tables within the body of the manuscript. They should be self-explanatory and should supplement, rather than duplicate, the material in the text.
Style: Pattern manuscript style after the American Medical Association Manual of Style (9th edition). Stedman¡¯s Medical Dictionary (27th edition) and Merriam Webster¡¯s Collegiate Dictionary (10th edition) should be used as standard references. Refer to drugs and therapeutic agents by their accepted generic or chemical names, and do not abbreviate them. Use code numbers only when a generic name is not yet available. In that case, the chemical name and a figure giving the chemical structure of the drug is required. Copyright or trade names of drugs should be capitalized and placed in parentheses after the name of the drug. Names and locations (city and state in USA; city and country outside USA) of manufacturers of drugs, supplies, or equipment cited in a manuscript are required to comply with trademark law and should be provided in parentheses. Units of measure should be expressed in the metric system, and temperatures should be expressed in degrees Celsius. Conventional units should be written as SI units as appropriate.
Sections
Original Articles: Our intent is to publish high quality research as it relates to clinical trials, outcome analyses, translational research, cost utility analyses, etc.
Brief Reports: Articles having a maximum of 1500 words and an abstract with a highly focused message and minimum of methodological detail, and maximum of 15 references. Include "Brief Report: " in the title.
Image(s) or Case(s) of the Month: Emphasis is on the images. Include up to 5 exceptional images with one or two short paragraphs of text.
Gene or Pathway of the Month: Maximum of 1000 words plus 1 or 2 illustrations covering genes or pathways important in development or treatment of thoracic malignancies.
Case Reports: Reports highlighting unusual presentations of malignancy, treatment outcome, toxicity, etc. Submissions must be a total of 500 words or less and may include up to 3 figures and no more than 4 references. Authors are encouraged to submit images and /or photographs which support the case being illustrated.
Letters to the Editor: The Editorial Board reserves the right to decline publishing insulting or inflammatory comments in letters to the editor. Letters should be a short and concise communication commenting on a recently published article in the Journal or commenting on a controversial current issue of concern to the readership. A Letter to the Editor is not a site for publication of original results. The letter should have no more than 3 authors and contain no more than 5 references, including a reference to the article in question. A statement of potential sources of conflict of interest must accompany the letter and may be published along with the letter.
After Acceptance
Page proofs and corrections: Corresponding authors will receive electronic page proofs to check the copyedited and typeset article before publication. Portable document format (PDF) files of the typeset pages and support documents (eg, reprint order form) will be sent to the corresponding author by e-mail. Complete instructions will be provided with the e-mail for downloading and printing the files and for faxing the corrected page proofs to the publisher. Those authors without an e-mail address will receive traditional page proofs. It is the author¡¯s responsibility to ensure that there are no errors in the proofs. Changes that have been made to conform to journal style will stand if they do not alter the authors' meaning. Only the most critical changes to the accuracy of the content will be made. Changes that are stylistic or are a reworking of previously accepted material will be disallowed. The publisher reserves the right to deny any changes that do not affect the accuracy of the content. Authors may be charged for alterations to the proofs beyond those required to correct errors or to answer queries. Proofs must be checked carefully and corrections faxed within 24 to 48 hours of receipt, as requested in the cover letter accompanying the page proofs.
Reprints: Authors will receive a reprint order form and a price list with the page proofs. Reprint requests should be faxed to the publisher with the corrected proofs, if possible. Reprints are normally shipped 6 to 8 weeks after publication of the issue in which the item appears. . Contact the Reprint Department, Lippincott Williams & Wilkins, 351 W. Camden Street, Baltimore, MD 21201; Fax: 410-528-4434; E-mail: reprints@wolterskluwer.com with any questions.
Publisher's contact: Fax corrected page proofs, reprint order form, and any other related materials to Journal Production Editor, Journal of Thoracic Oncology, 351 W. Camden Street, Baltimore, MD 21201-2436; 410-528-4350 (ph), 410-361-8040 (fax).
Editorial Board
Editorial Board & Publication Staff
|
Editor-in-Chief
James R. Jett, MD
Pulmonary Medicine and Medical Oncology
Mayo Clinic
Rochester, MN
Deputy Editor
David Midthun, MD
USA
Chest Medicine
|
Statistical Editor
John J. Crowley, PhD
Seattle, WA
|
| Associate Editors, Europe |
Ramon Rami-Porta, MD
Spain
Thoracic Surgeon
Johan Vansteenkiste, MD
Belgium
Chest Medicine/Medical Oncology
Wilfried Eberhardt, MD
Germany
Medical Oncology
Thierry Le Chevalier, MD
France
Medical Oncology
|
Giorgio Scagliotti, MD
Italy
Medical Oncology/Chest Medicine
Jacek Jassem, MD
Poland
Medical Oncology and Radiation Oncology
Rodrigo Arriagada, MD
France/Sweden
Radiation Oncology
Jean Louis Pujol, MD
Montpellier, France
Chest Medicine, Medical Oncology
|
| Associate Editors, Asia |
Hisao Asamura, MD
Japan
Thoracic Surgeon
Masahiro Tsuboi, MD
Japan
Thoracic Surgeon
Masahiro Fukuoka, MD
Japan
Medical Oncology
|
|
Masayuki Noguchi, MD
Japan
Pathology
Nagahiro Saijo, MD
Japan
Medical Oncology
Jin Soo Lee, MD
South Korea
Medical Oncology
Toni Mok, MD
Hong Kong, China
Clinical Oncology
|
|
| Associate Editors, North America |
Harvey Pass, MD
USA
Thoracic Surgeon
Frances Shepherd, MD
Canada
Medical Oncology
Ritsuko Komaki, MD
USA
Radiation Oncology
|
|
William Travis, MD
USA
Pathology
Fred R. Hirsch, MD, Ph.D.
USA
Translational Research
Edward F. Patz, Jr., MD
USA
Radiology
|
|
| Associate Editors, Rest of World |
David Ball, MD
Radiation Oncology
Australia
|
|
Raymond P. Abratt, MD
Medical Oncology and Radiation Oncology
South Africa
|
|
Publication Staff
Mary Sharkey
Managing Editor
New York
|
David Myers
Publisher
Philadelphia |
|
|
|
|
